To view or add a comment, sign in Clinical Trial Win Bolsters Blockbuster Prospects for Roivant Rare Disease Drug Licensed From Pfizer Brepocitinib is on track for pivotal testing after meeting the goals of a proof-of-concept study in cutaneous sarcoidosis, a rare inflammatory skin disorder with no FDA-approved therapies
Furthermore, a statistical analysis of over one million medical records found a correlative link between the use of sitagliptins (like Januvia and Janumet) with higher rates and risk of pancreatic cancer
doi: 10.1016/S8756-3282(98)00180-X
Rastogi A, Thakore P, Leung A, Benavides M, Machado M, Morschauser MA, Hsieh AH: Environmental regulation of notochordal gene expression in nucleus pulposus cells
This gluten-free powder is packaged for quality and freshness.
Each batch of L-carnitine is verified at 99% purity by reversed-phase HPLC, with identity confirmed by mass spectrometry against its 161.2 Da molecular weight